Literature DB >> 19805972

Metastatic rhabdomyosarcomatous elements, mimicking a primary sarcoma, in the omentum, from a poorly differentiated ovarian Sertoli-Leydig cell tumor in a young girl: an unusual presentation with a literature review.

Bharat Rekhi1, Arti Karpate, Kedar K Deodhar, R F Chinoy.   

Abstract

Sertoli-Leydig cell tumors (SLCTs) of the ovary with mesenchymal heterologous elements are uncommon. Only few such cases have been documented, showing presence of only mesenchymal heterologous elements at the metastatic site. We report an unusual case in a young girl who presented with an omental mass that was consistent with histopathological features of a high-grade sarcoma, with prominent rhabdomyoblastic differentiation of the embryonal type. The sections from her ovarian mass for which she was operated a year back displayed features of a poorly differentiated SLCT with heterologous elements, including focal rhabdomyoblastic differentiation. This is one of the rare cases, to the best of our knowledge, where only rhabomyosarcomatous elements were identified at the metastatic site, mimicking a primary abdominal rhabdomyosarcoma, in a case of an ovarian SLCT. Further, this case reinforces the presence of rhabdomyosarcomatous elements in an ovarian SLCT to be associated with an aggressive disease course.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805972     DOI: 10.4103/0377-4929.56165

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  2 in total

1.  Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature.

Authors:  Trisha Plastini; Arthur Staddon
Journal:  Case Rep Med       Date:  2017-07-02

2.  Poorly differentiated, ovarian Sertoli-Leydig cell tumor with heterologous rhabdomyosarcoma and glandular elements: Diagnosis and management of a rare neoplasm.

Authors:  Charanjeet Singh; Sarfraz Ahmad; Fouad M Hajjar; Robert W Holloway
Journal:  Gynecol Oncol Rep       Date:  2018-06-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.